Method for detecting ovarian cancer

Details for Australian Patent Application No. 2006316862 (hide)

Owner The Cleveland Clinic Foundation Frantz Biomarkers, LLC

Inventors Hazen, Stanley L.; Shan, Lian

Agent IP Gateway Patent and Trademark Attorneys

Pub. Number AU-A-2006316862

PCT Pub. Number WO2007/061656

Priority 60/738,849 22.11.05 US; 11/595,634 10.11.06 US

Filing date 13 November 2006

Wipo publication date 31 May 2007

International Classifications

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/061656 Priority application(s): WO2007/061656

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316867-Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

2006316858-A method of tracking dual mode data objects using related thumbnails and tool icons in a palette window